1. Enantioselective synthesis of 4-amino-3,4-dihydrocoumarins and their non-cyclic hydroxyester precursors: Biological evaluation for the treatment of glioblastoma multiforme
- Author
-
Lorenzo G. Borrego, Rocío Recio, Nazaret Moreno, Ahmed Chelouan, Eleuterio Álvarez, Antonio Sánchez-Coronilla, Carlos Caro, John R. Pearson, Maria Luisa García-Martín, Noureddine Khiar, Inmaculada Fernández, Universidad de Sevilla. Departamento de Química Orgánica y Farmacéutica, Universidad de Sevilla. Departamento de Química Física, Ministerio de Ciencia, Innovación y Universidades (MICINN). España, and Junta de Andalucía
- Subjects
Pharmacology ,Organic Chemistry ,Drug Discovery ,N-sulfinylarylimines ,Enantiopure 4-amino-3,4-dihydrocoumarins ,Humans ,Stereoisomerism ,Esters ,Antineoplastic Agents ,General Medicine ,β-hydroxyesters ,Glioblastoma multiforme ,Glioblastoma - Abstract
The stereoselective addition of ethyl acetate enolate to the C═N bond of N-tert-butylsulfinylimines has been investigated in depth. A significant effect of the LHMDS amount and the N-sulfinylimine nature on the stereoselectivity of the process was observed. Conditions were found where sulfinylimines of differently substituted salicylaldehydes derivatives, ethyl acetate, and LHMDS afforded the corresponding addition products as a single diastereomer in good yields. The developed protocol was successfully applied to the first stereoselective synthesis of differently substituted 4-amino-3,4-dihydrocoumarin derivatives. Computational models confirmed the prominent role of the ortho aryl substituent in the stereoselectivity of the process. A significant and selective cytotoxic activity against Glioblastoma Multiforme (GBM) cancer line has been determined for the noncyclic hydroxy ester derivative. Ministerio de Ciencia e Innovación PID2019-104767RB-I00 Junta de Andalucía US- 1381590, FQM-106
- Published
- 2022